Search results
Results from the WOW.Com Content Network
As ovarian cancer is rarely symptomatic until an advanced stage, [42] regular pre-emptive screening is a particularly important tool for avoiding the late stage at which most patients present. However, A 2011 US study found that transvaginal ultrasound and cancer marker CA125 screening did not reduce ovarian cancer mortality. [43]
Women with ovarian cancer may not need routine surveillance imaging to monitor the cancer unless new symptoms appear or tumor markers begin rising. [123] Imaging without these indications is discouraged because it is unlikely to detect a recurrence, improve survival, and because it has its own costs and side effects. [123]
While cancer screening has long been promoted as a sensible thing to do, a new study of ovarian cancer is the latest showing that cancer screening can have a significant downside.
Breast cancer is the most common cancer women face. Ovarian cancer is a type of cancer which begins in the ovaries. Anyone with ovaries can get it, including women, trans men, non-binary people and intersex people. [2] Although ovarian cancer is much less frequent, it is the deadliest among gynecologic cancers. [3] Early signs of possible ...
Ovarian squamous cell carcinoma (oSCC) or squamous ovarian carcinoma (SOC) is a rare tumor that accounts for 1% of ovarian cancers. [1] Included in the World Health Organization 's classification of ovarian cancer, [ 2 ] it mainly affects women above 45 years of age.
Usha Menon is Professor of Gynaecological Cancer at University College London, described as "one of Britain’s foremost specialists in gynaecological cancer". [1] [2]She has been a lead investigator on UK ovarian cancer screening trials and on studies of ovarian cancer symptoms notably the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), [3] which forms the evidence base for ...
Even with poor existing screening methods, around 20% of women with ovarian cancer are still effectively caught and diagnosed at early stages in the U.S. [37] Research has revealed that not having private health insurance coverage decreases a woman's chance of being diagnosed with early stage ovarian cancer. [37] African American women are less ...
The consequences of overdiagnosis and overtreatment resulting from cancer screening can lead to a decline in quality of life, due to the adverse effects of unnecessary medication and hospitalization. [10] [12] [13] The accuracy of a cancer screening test relies on its sensitivity, and low sensitivity screening tests can overlook cancers. [10]